1. Market Research
  2. > Pathology
41 reports for Lymphoma (page 2)

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • September 2017
  • 433 pages

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026 Summary Melanoma is the deadliest and most aggressive form of skin cancer. Melanoma is rare compared to other major cancer indications, ...

  • Hospital
  • Lymphoma
  • Therapy
  • Australasia
  • Merck & Co., Inc.

Heparanase - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 43 pages

Initially, it stimulates the DC, leading to the activation of natural killer (NK) cells that are capable of destroying lymphomas.

  • Lymphoma
  • Therapy
  • Australasia
  • Product Initiative
  • Progen Pharmaceuticals Limited

Australia In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

  • $ 5995
  • April 2020
  • 503 pages

ASSOCIATE PROFESSOR WIEGMANS SAID THE STUDY COULD HAVE IMPLICATIONS FOR SEVERAL OTHER CANCERS WHERE DOXORUBICIN WAS USED, SUCH AS BLADDER, STOMACH, LUNG, OVARIAN, AND THYROID CANCERS AND SOME TYPES OF LEUKAEMIA AND HODGKIN S LYMPHOMA.

  • Infectious Disease
  • Lymphoma
  • Australasia
  • Australia
  • Oceania

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 152 pages

IT WAS ALSO UNDER DEVELOPMENT FOR METASTATIC PANCREATIC CANCER, ADVANCED SOLID TUMOR MALIGNANCIES OR LYMPHOMA.

  • Chemotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Pharmaceutical
  • Australasia

Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2017

  • $ 2000
  • December 2017
  • 44 pages

Tumor volume reduction was seen in ##% of lymphoma case.

  • Digestive System Disorder
  • Lymphoma
  • Therapy
  • Australasia
  • Anthera Pharmaceuticals, Inc.

Australia Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others

  • $ 5995
  • July 2019
  • 352 pages

Australia Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others Summary GlobalData’s ...

  • Lymphoma
  • Wound Care
  • Australasia
  • Australia
  • Oceania

CSL Ltd (CSL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 95 pages

CSL Ltd (CSL) Pharmaceuticals & Healthcare - Deals and Alliances Profile Report Code: GDPH##D Published: November 2018 CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products.

  • Lymphoma
  • Pharmaceutical
  • Vaccine
  • Australasia
  • CSL Limited

Rosetta Genomics Ltd - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • December 2018
  • 59 pages

lymphomas.

  • Genomics
  • Lymphoma
  • Medical Device
  • Australasia
  • Rosetta Genomics Ltd.

Australia & New Zealand Diagnostic Imaging Equipment Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 3250
  • February 2019
  • 103 pages

Hence, the basic applications of the SPECT are involved in the area of Cardiology, Lymphoma, Thyroid, Neurology, and other areas of expertise.

  • Diagnostic Imaging
  • Healthcare
  • Lymphoma
  • Australasia
  • New Zealand

Peter MacCallum Cancer Centre - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 28 pages

They are combining Dinaciclib with the anti-PD## therapy, Keytruda, in relapsed lymphoma, myeloma and chronic lymphocytic leukaemia.

  • Health Services
  • Lymphoma
  • Pharmaceutical
  • Specialty Hospital
  • Australasia

EnGeneIC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 19 pages

The company' s product Velcade is used for the treatment of multiple myeloma and relapsed mantle cell lymphoma.

  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • Australasia
  • EnGeneIC Ltd

Diabetic Nephropathy - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 264 pages

Diabetic Nephropathy - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H1 2020, provides an overview of the Diabetic ...

  • Hospital
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Australasia

Specialised Therapeutics Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 25 pages

Ariad' s pipeline portfolio comprises three promising molecules including Iclusig, a novel oral multi-targeted kinase inhibitor; Brigatinib, an anaplastic lymphoma kinase inhibitor; and AP##, a drug candidate, for the treatment of patients with NSCLC with specific mutations in the EG

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Australasia
  • Australia

Diabetic Nephropathy - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 250 pages

Diabetic Nephropathy - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2019, provides an overview of the Diabetic ...

  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Australasia

Amcor Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 118 pages

Lymphomas Pharmaceuticals and Healthcare--> Therapy Area-- > Oncology--> Solid Tumors--> Sarcoma--> Bone Sarcomas DIVESTMENTS Pharmaceuticals and Healthcare--> Therapy Area-- > Oncology--> Solid Tumors--> Breast Cancer Pharmaceuticals and Healthcare--> Therapy Area-- >

  • Lymphoma
  • Packaging
  • Australasia
  • M&A
  • Amcor Limited

Amcor Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • April 2018
  • 117 pages

Lymphomas Pharmaceuticals and Healthcare--> Therapy Area-- > Oncology--> Solid Tumors--> Sarcoma--> Bone Sarcomas DIVESTMENTS Pharmaceuticals and Healthcare--> Therapy Area-- > Oncology--> Solid Tumors--> Breast Cancer Pharmaceuticals and Healthcare--> Therapy Area-- >

  • Lymphoma
  • Packaging
  • Australasia
  • M&A
  • Amcor Limited

Australia In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

  • $ 5995
  • December 2017
  • 544 pages

TRANSPLANTS ARE USED TO REPLACE DISEASED OR CANCEROUS BONE MARROW WITH HEALTHY BONE MARROW TO TREAT A RANGE OF DISEASES INCLUDING LEUKEMIA, LYMPHOMA AND IMMUNE DEFICIENCY DISORDERS.

  • In Vitro Diagnostic Reagent
  • Lymphoma
  • Australasia
  • Australia
  • Oceania

Hutchison MediPharma Ltd - Product Pipeline Review - 2016

  • $ 1500
  • December 2016
  • 49 pages

This study is in patients with relapsed and/ or refractory B-cell non-Hodgkin s lymphoma or chronic lymphocytic leukemia for whom there is no standard therapy.

  • Lymphoma
  • Therapy
  • Australasia
  • Product Initiative
  • Hutchison MediPharma Limited

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, H2 2017

  • $ 3500
  • August 2017
  • 74 pages

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, H2 2017 Summary Sphingosine ...

  • Autoimmune Disease
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Australasia

Celltrion, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • July 2016
  • 40 pages

It was also under development for diffuse large B-cell lymphoma,.

  • Biosimilar
  • Lymphoma
  • Monoclonal Antibody
  • Australasia
  • Celltrion, Inc.
View report >

Cancer Statistics

  • February 2020
  • 66 pages

Salivary gland Polycythaemia vera Oropharynx Other lymphomas Thymus Eye Nose, nasal cavities, middle ear and accessory sinuses Larynx Other endocrine glands Skin of anus (including perineum, perianal skin) Nasopharynx Malignancy of histiocytes and accessory lymphoid cells Unspecified sites

  • Cancer
  • Lymphoma
  • Pathology
  • Australasia
  • Demographic

Cancer Statistics June 2019

Cancer Statistics January 2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on